These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1479559)

  • 1. Biopharmaceutical evaluation of ibufenac, ibuprofen, and their hydroxyethoxy analogs in the rabbit eye.
    Rao CS; Schoenwald RD; Barfknecht CF; Laban SL
    J Pharmacokinet Biopharm; 1992 Aug; 20(4):357-88. PubMed ID: 1479559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition and reactivity of ibuprofen and ibufenac acyl glucuronides in vivo in the rhesus monkey and in vitro with human serum albumin.
    Castillo M; Smith PC
    Drug Metab Dispos; 1995 May; 23(5):566-72. PubMed ID: 7587932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular pharmacokinetic models of clonidine-3H hydrochloride.
    Chiang CH; Schoenwald RD
    J Pharmacokinet Biopharm; 1986 Apr; 14(2):175-211. PubMed ID: 3746638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: II. In vitro bioactivation and permeation of external ocular barriers.
    Ke TL; Graff G; Spellman JM; Yanni JM
    Inflammation; 2000 Aug; 24(4):371-84. PubMed ID: 10850858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical carbonic anhydrase inhibitors IV: Relationship between excised corneal permeability and pharmacokinetic factors.
    Eller MG; Schoenwald RD; Dixson JA; Segarra T; Barfknecht CF
    J Pharm Sci; 1985 May; 74(5):525-9. PubMed ID: 4020628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of topical ocular nepafenac and its active metabolite amfenac to the posterior segment of the eye.
    Chastain JE; Sanders ME; Curtis MA; Chemuturi NV; Gadd ME; Kapin MA; Markwardt KL; Dahlin DC
    Exp Eye Res; 2016 Apr; 145():58-67. PubMed ID: 26474497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biopharmaceutical explanation for the topical activity of 6-hydroxyethoxy-2-benzothiazolesulfonamide in the rabbit eye.
    Lee DY; Schoenwald RD; Barfknecht CF
    J Ocul Pharmacol; 1992; 8(3):247-65. PubMed ID: 1453087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Situ Gel Formulation for Enhanced Ocular Delivery of Nepafenac.
    Shelley H; Rodriguez-Galarza RM; Duran SH; Abarca EM; Babu RJ
    J Pharm Sci; 2018 Dec; 107(12):3089-3097. PubMed ID: 30170009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of topical S(+)-ibuprofen on interleukin-1 induced ocular inflammation in a rabbit model.
    Tilden ME; Boney RS; Goldenberg MM; Rosenbaum JT
    J Ocul Pharmacol; 1990; 6(2):131-5. PubMed ID: 2394932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro permeation and in vivo anti-inflammatory and analgesic properties of nanoscaled emulsions containing ibuprofen for topical delivery.
    Abdullah GZ; Abdulkarim MF; Salman IM; Ameer OZ; Yam MF; Mutee AF; Chitneni M; Mahdi ES; Basri M; Sattar MA; Noor AM
    Int J Nanomedicine; 2011; 6():387-96. PubMed ID: 21499428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability of two dermal formulations of S(+)ibuprofen in rabbit.
    González-Peñas E; Echeverría HC; Mosquera J; Esteras A; Bruseghini L
    Arzneimittelforschung; 2003; 53(11):786-92. PubMed ID: 14677375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preparation of diclofenac sodium liposomes and its ocular pharmacokinetics].
    Sun KX; Wang AP; Huang LJ; Liang RC; Liu K
    Yao Xue Xue Bao; 2006 Nov; 41(11):1094-8. PubMed ID: 17262954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of corneal drug penetration. I: In vivo and in vitro kinetics.
    Grass GM; Robinson JR
    J Pharm Sci; 1988 Jan; 77(1):3-14. PubMed ID: 3126290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular pharmacokinetics of topically-applied ketoconazole solution containing hydroxypropyl beta-cyclodextrin to rabbits.
    Zhang J; Wang L; Gao C; Zhang L; Xia H
    J Ocul Pharmacol Ther; 2008 Oct; 24(5):501-6. PubMed ID: 18803444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and evaluation of ibuprofen-loaded microemulsion for improvement of oral bioavailability.
    Hu L; Yang J; Liu W; Li L
    Drug Deliv; 2011 Jan; 18(1):90-5. PubMed ID: 20942639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pH on the ocular distribution of a topical carbonic anhydrase inhibitor.
    Conroy CW; Maren TH
    Exp Eye Res; 1995 Aug; 61(2):213-22. PubMed ID: 7556485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ocular pharmacokinetics of topical diclofenac is affected by ocular inflammation.
    Palmero M; Bellot JL; Alcoriza N; García-Cabanes C; Orts A
    Ophthalmic Res; 1999; 31(4):309-16. PubMed ID: 10325547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved Ocular Delivery of Nepafenac by Cyclodextrin Complexation.
    Shelley H; Grant M; Smith FT; Abarca EM; Jayachandra Babu R
    AAPS PharmSciTech; 2018 Aug; 19(6):2554-2563. PubMed ID: 29948988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular pharmacokinetics of a novel tetrahydroquinoline analog in rabbit: absorption, disposition, and non-compartmental analysis.
    Pamulapati CR; Schoenwald RD
    J Pharm Sci; 2011 Dec; 100(12):5315-23. PubMed ID: 21850670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption of sodium diclofenac after ocular administration in rabbit.
    González-Peñas E; Aldana I; Esteras A; Bruseghini L; Gazzaniga A; Gianesello W
    Arzneimittelforschung; 1998 Sep; 48(9):931-4. PubMed ID: 9793621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.